|
US599387A
(en)
*
|
|
1898-02-22 |
|
Cabinet |
|
US4772607A
(en)
*
|
1986-05-20 |
1988-09-20 |
Warner-Lambert Company |
Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
|
|
US4780464A
(en)
*
|
1986-12-08 |
1988-10-25 |
Warner-Lambert Company |
(1,2,4)triazolo(4,3-a)quinoxaline-4-amines
|
|
ATE176470T1
(de)
|
1990-10-18 |
1999-02-15 |
Kyowa Hakko Kogyo Kk |
Xanthinderivate
|
|
GB9124968D0
(en)
*
|
1991-11-25 |
1992-01-22 |
Ici Plc |
Chemical process
|
|
US5484920A
(en)
|
1992-04-08 |
1996-01-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Therapeutic agent for Parkinson's disease
|
|
DE69331843T2
(de)
|
1992-07-08 |
2002-09-26 |
Kyowa Hakko Kogyo Co., Ltd. |
Xanthine-Derivate als Antidepressiva
|
|
IT1264901B1
(it)
|
1993-06-29 |
1996-10-17 |
Schering Plough S P A |
Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
|
|
CA2144330A1
(en)
|
1993-07-27 |
1995-02-09 |
Fumio Suzuki |
A therapeutic agent for parkinson's disease
|
|
US5736528A
(en)
*
|
1993-10-28 |
1998-04-07 |
University Of Florida Research Foundation, Inc. |
N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
|
|
WO1995023148A1
(en)
|
1994-02-23 |
1995-08-31 |
Kyowa Hakko Kogyo Co., Ltd. |
Xanthine derivative
|
|
IT1277392B1
(it)
|
1995-07-28 |
1997-11-10 |
Schering Plough S P A |
Analoghi eterociclici di 1,2,4-triazolo(1,5-c]pirimidine ad attivita' antagonista per il recettore a2a dell'adenosina
|
|
US6051578A
(en)
*
|
1996-02-12 |
2000-04-18 |
Pfizer Inc. |
Pyrazolopyrimidines for treatment of CNS disorders
|
|
US6060478A
(en)
*
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
|
AU743910B2
(en)
|
1997-03-24 |
2002-02-07 |
Kyowa Hakko Kirin Co., Ltd. |
{1,2,4}triazolo{1,5-c}pyrimidine derivatives
|
|
IT1291372B1
(it)
|
1997-05-21 |
1999-01-07 |
Schering Plough S P A |
Uso di analoghi eterociclici di 1,2,4-triazolo (1,5-c) pirimidine per la preparazione di medicamenti utili per il trattamento delle malattie
|
|
ATE325610T1
(de)
|
1997-09-05 |
2006-06-15 |
Kyowa Hakko Kogyo Kk |
Xanthinderivative zur behandlung von hirnischämie
|
|
AU1251499A
(en)
|
1997-11-26 |
1999-06-15 |
Cerebrus Limited |
(-)-mefloquine to block purinergic receptors and to treat movement or neurodegenerative disorders
|
|
EP1054012B1
(en)
|
1998-01-05 |
2003-06-11 |
Eisai Co., Ltd. |
Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes
|
|
WO1999043678A1
(en)
|
1998-02-24 |
1999-09-02 |
Kyowa Hakko Kogyo Co., Ltd. |
Remedies/preventives for parkinson's disease
|
|
DE19930558A1
(de)
|
1998-07-24 |
2000-01-27 |
Marquardt Gmbh |
Elektrischer Schalter
|
|
GB9819382D0
(en)
|
1998-09-04 |
1998-10-28 |
Cerebrus Ltd |
Chemical compounds I
|
|
GB9819384D0
(en)
|
1998-09-04 |
1998-10-28 |
Cerebrus Ltd |
Chemical compounds II
|
|
CA2341353A1
(en)
*
|
1998-09-04 |
2000-03-16 |
The Procter & Gamble Company |
Substituted dihydrobenzopyrans useful as antiarrhythmic agents
|
|
AU4431000A
(en)
|
1999-05-12 |
2000-12-05 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel use
|
|
US6545002B1
(en)
|
1999-06-01 |
2003-04-08 |
University Of Virginia Patent Foundation |
Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
|
|
GB9915437D0
(en)
|
1999-07-01 |
1999-09-01 |
Cerebrus Ltd |
Chemical compounds III
|
|
CA2376835C
(en)
|
1999-07-02 |
2009-09-15 |
Eisai Co., Ltd. |
Condensed imidazole compounds and a therapeutic agent for diabetes mellitus
|
|
JP3347691B2
(ja)
*
|
1999-07-05 |
2002-11-20 |
プロクター、エンド、ギャンブル、ファーマスーティカルズ、インコーポレーテッド |
抗不整脈及び抗細動剤として有用な新規４−オキソ環式尿素類
|
|
NZ517546A
(en)
|
1999-08-31 |
2003-10-31 |
Univ Vanderbilt |
Selective antagonists of A2B adenosine receptors
|
|
US6355653B1
(en)
|
1999-09-06 |
2002-03-12 |
Hoffmann-La Roche Inc. |
Amino-triazolopyridine derivatives
|
|
DE19947154A1
(de)
|
1999-10-01 |
2001-10-04 |
Bayer Ag |
Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
|
|
US6194366B1
(en)
|
1999-11-16 |
2001-02-27 |
Esc, Inc. |
Post chemical-mechanical planarization (CMP) cleaning composition
|
|
AUPQ441499A0
(en)
|
1999-12-02 |
2000-01-06 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel compound
|
|
US6258793B1
(en)
*
|
1999-12-03 |
2001-07-10 |
Cv Therapeutics, Inc. |
N6 heterocyclic 5′ modified adenosine derivatives
|
|
MY125533A
(en)
*
|
1999-12-06 |
2006-08-30 |
Bristol Myers Squibb Co |
Heterocyclic dihydropyrimidine compounds
|
|
CN1438890A
(zh)
|
2000-02-25 |
2003-08-27 |
弗·哈夫曼-拉罗切有限公司 |
腺苷受体调制剂
|
|
IL152023A0
(en)
|
2000-04-26 |
2003-04-10 |
Eisai Co Ltd |
Compounds having adenosine a2 receptor antagonism and pharmaceutical compositions containing the same
|
|
EP1283839B1
(en)
|
2000-05-26 |
2005-04-20 |
Schering Corporation |
Adenosine a2a receptor antagonists
|
|
CN1234358C
(zh)
|
2000-06-21 |
2006-01-04 |
弗·哈夫曼-拉罗切有限公司 |
苯并噻唑衍生物
|
|
RU2250898C2
(ru)
|
2000-08-11 |
2005-04-27 |
Эйсай Ко., Лтд. |
Производные 2-аминопиридина, фармацевтическая композиция на их основе и способ лечения
|
|
GB0100620D0
(en)
*
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical cokpounds V
|
|
MY124864A
(en)
|
2001-10-15 |
2006-07-31 |
Schering Corp |
Adenosine a2a receptor antagonists
|
|
US6599901B1
(en)
*
|
2001-11-19 |
2003-07-29 |
Hoffman-La Roche Inc. |
Pyridone substituted benzothiazole derivatives
|
|
AR038366A1
(es)
|
2001-11-30 |
2005-01-12 |
Schering Corp |
Compuestos de 1,2,4-triazolo [1,5-c] pirimidinas sustituidas, antagonistas del receptor de adenosina a2a, composiciones farmaceuticas, el uso de dichos compuestos para la manufactura de un medicamento para el tratamiento de enfermedades del sistema nervioso central y un kit que comprende combinacion
|
|
US6916811B2
(en)
|
2001-11-30 |
2005-07-12 |
Schering Corporation |
Adenosine A2a receptor antagonists
|
|
US6875772B2
(en)
|
2001-11-30 |
2005-04-05 |
Schering Corporation |
[1,2,4]-Triazole bicyclic adeonsine A2a receptor antagonists
|
|
AU2002357295A1
(en)
|
2001-12-18 |
2003-06-30 |
Cv Therapeutics, Inc. |
A2a adenosine receptor antagonists
|
|
US20050043315A1
(en)
|
2002-01-02 |
2005-02-24 |
Hideo Tsutsumi |
Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
|
|
ES2208063B1
(es)
|
2002-04-01 |
2005-10-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de la 4-(pirrolopirimidin-6-il)bencenosulfonamida.
|
|
AU2002950853A0
(en)
|
2002-08-19 |
2002-09-12 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminopyrimidine compound and pharmaceutical use thereof
|
|
ES2310258T5
(es)
|
2002-08-30 |
2012-05-31 |
Kyowa Hakko Kogyo Co., Ltd. |
Antagonistas de los receptores de adenosina A2A para tratar el síndrome de piernas inquietas o mioclono nocturno
|
|
CA2500228A1
(en)
|
2002-09-24 |
2004-04-08 |
Kyowa Hakko Kogyo Co., Ltd. |
[1,2,4]-triazolo[1,5-c]pyrimidine derivative
|
|
BR0317436A
(pt)
|
2002-12-19 |
2005-11-16 |
Schering Corp |
Usos de antagonistas do receptor a2a de adenosina
|
|
CA2520251A1
(en)
*
|
2003-03-27 |
2004-10-07 |
Pfizer Products Inc. |
Substituted 4-amino[1,2,4]triazolo[4,3-a]quinoxalines
|
|
WO2004092177A1
(en)
|
2003-04-09 |
2004-10-28 |
Biogen Idec Ma Inc. |
Triazolopyrazines and methods of making and using the same
|
|
MY139344A
(en)
|
2003-04-23 |
2009-09-30 |
Schering Corp |
2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists
|
|
AU2003275430A1
(en)
|
2003-10-03 |
2005-05-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist
|
|
TW200524887A
(en)
|
2003-10-27 |
2005-08-01 |
Lundbeck & Co As H |
N-thiazol-2-yl-benzamide derivatives
|
|
EP1678160A1
(en)
|
2003-10-27 |
2006-07-12 |
Astellas Pharma Inc. |
Pyrazine derivatives and pharmaceutical use thereof
|
|
ES2293380T3
(es)
|
2003-12-01 |
2008-03-16 |
Schering Corporation |
Procedimiento para preparar 5-amino-pirazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pirimidinas sustituidos.
|
|
SMAP200600024A
(it)
|
2003-12-15 |
2006-07-19 |
Almirall Prodesfarma Ag |
2,6-Biseteroaril-4-amminopirimidine come antagonisti del recettore dell'adenosia
|